Home › Kidney Cancer › Arizona › Phoenix
Kidney Cancer clinical trials in Phoenix, AZ
5 studies for Kidney Cancer are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
- Research Site, Phoenix
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Mayo Clinic Hospital, Phoenix
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Mayo Clinic Building- Phoenix, Phoenix
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- Xencor Investigative Site, Phoenix
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RecruitingPhase 1
- Mayo Clinic Comprehensive Cancer Center, Phoenix
About Kidney Cancer
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
More about Kidney Cancer on MedlinePlus
Kidney Cancer trials in other cities
- New York City, NY15 studies
- Boston, MA12 studies
- Nashville, TN12 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
- San Diego, CA9 studies
- Edison, NJ8 studies
- Seattle, WA8 studies
- Los Angeles, CA7 studies
- Rochester, MN7 studies
Other studies in Phoenix
- Colorectal Cancer25 studies
- Breast Cancer25 studies
- Obesity23 studies
- Metastatic Cancer20 studies
- Non-Small Cell Lung Cancer20 studies
- Heart Failure18 studies
- Pancreatic Cancer17 studies
- Cancer (all types)17 studies
- Prostate Cancer17 studies
- Multiple Myeloma16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.